Company intelligence / Profile preview

HuiyiHuiying

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

HuiyiHuiying provides commercially deployed AI-powered medical imaging and full-cycle health management cloud platforms used for radiology decision support, cancer and chronic disease screening, and population-level health management; it does not develop drugs and has no therapeutic clinical trial pipeline, but its software is used clinically in hospitals as decision-support and management tools[2][4][5][6].

Therapeutic areas: OncologyCardiovascularOther
Modalities: DeviceNon-pharmacological therapySoftware as a medical device
Industry: Medical Imaging

Partnerships

Clinical deployments and collaborations with Chinese hospitals and health systems for AI medical imaging and full-cycle health management platforms (specific institutions not consistently named across sources)[4][5][6]

Beyond the preview

Go deeper on HuiyiHuiying.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HuiyiHuiying.

Explore the full profile